China Resources Pharmaceutical Group Ltd. logo

China Resources Pharmaceutical Group Ltd. (CRPGF)

Market Closed
31 Jul, 20:00
OTC PINK OTC PINK
$
0. 56
0
0%
$
3.84B Market Cap
- P/E Ratio
0.36% Div Yield
300 Volume
- Eps
$ 0.56
Previous Close
Add Transaction
Day Range
0.56 0.56
Year Range
0.56 0.56
Want to track CRPGF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CRPGF closed Friday higher at $0.56, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, CRPGF stock gained 0%.
CRPGF pays dividends to its shareholders, with the most recent payment made on Aug 03, 2026. The next estimated payment will be in 1 weeks ago on Aug 03, 2026 for a total of $0.0177.
The last earnings report, released on Mar 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
China Resources Pharmaceutical Group Ltd. has completed 1 stock splits, with the recent split occurring on May 02, 2017.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

CRPGF Chart

People also search for

Isuzu Motors Ltd. Unsponsored ADR
$ 14.47
-0.138%
Biomerieux SA - Unsponsored ADR
$ 8.82
0%
Shoprite Holdings Ltd Sponsored ADR
$ 17.5
-2.3982%
Pandora A/S
$ 14.92
-2.1639%
Renault S.A.
$ 6.51
-0.9132%

China Resources Pharmaceutical Group Ltd. (CRPGF) FAQ

What is the stock price today?

The current price is $0.56.

On which exchange is it traded?

China Resources Pharmaceutical Group Ltd. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is CRPGF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.36%.

What is its market cap?

As of today, the market cap is 3.84B.

Has China Resources Pharmaceutical Group Ltd. ever had a stock split?

China Resources Pharmaceutical Group Ltd. had 1 splits and the recent split was on May 02, 2017.

China Resources Pharmaceutical Group Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Xiaosong Bai CEO
OTC PINK Exchange
HK0000311099 ISIN
Hong Kong Country
72,764 Employees
3 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

China Resources Pharmaceutical Group Limited, a significant player in the healthcare and pharmaceutical sectors, incorporates a comprehensive approach to its business by engaging in the research, development, manufacture, distribution, and retail of pharmaceutical and other healthcare products. Primarily operating in Mainland China and Hong Kong, the company functions through four main segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. Originally known as China Resources Medications Group Limited, it rebranded to its current name in December 2011. Established in 2007 and headquartered in Wan Chai, Hong Kong, this subsidiary of CRH (Pharmaceutical) Limited has a broad operational scope, catering to various healthcare needs through its extensive product portfolio and services. It distinguishes itself through a potent mix of manufacturing, comprehensive distribution network, and retail capabilities, all aimed at improving healthcare accessibility and efficiency.

Products and Services

The company's offerings span across a wide array of healthcare needs, ensuring a comprehensive approach to wellbeing and medical care:

  • Chemical Drugs: These encompass a broad range of medication designed to address various health conditions, leveraging chemical science for therapeutic benefits.
  • Chinese Medicines: Traditional Chinese medicines are offered, tapping into centuries-old practices and natural remedies for health and wellness.
  • Biopharmaceutical Drugs: Focusing on biologically based treatments, these drugs represent the cutting-edge of therapeutic innovation, targeting a wide range of illnesses with precision medicine.
  • Nutritional and Healthcare Products: A variety of products aimed at promoting general health, addressing nutritional deficiencies, and supporting disease prevention efforts.
  • Pharmaceutical Manufacturing: The segment involves the production of a diverse drug portfolio, ensuring high-quality manufacturing practices and compliance with global standards.
  • Pharmaceutical Distribution: This includes warehousing, logistics, and other pharmaceutical supply chain solutions, aimed at efficiently distributing products to hospitals, distributors, and pharmacies.
  • Pharmaceutical Retail: With retail pharmacies operating under the CR Care and Teck Soon Hong brands, this segment ensures direct access to medicines and healthcare products for consumers.
  • Other Services: In addition to its core offerings, the company engages in property holding activities and provides value-added services related to the pharmaceutical supply chain to enhance the overall efficiency and effectiveness of healthcare product distribution.

Contact Information

Address: China Resources Building
Phone: 852 2593 8991